ARANESP

Google image searchProduct monograph

Active ingredient

darbepoetin alfa, 100 MCG/ML

DIN: 02391740

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Description: HSA-FREE. 40MCG/0.4ML SINGLE-USE PREFILLED SYRINGES (SINGLEJECT)

Schedule: Prescription / Schedule D

Company: AMGEN CANADA INC

Date: 11-DEC-2013

ATC:

Reference brand drug: Aranesp

Search on Google